Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells

International Journal of Cancer

Volumn 70, Issue 1, 1997, Pages 128-134

  Thurnher, Martin ^a   Ramoner, Reinhold ^a   Gastl, Günther ^b   Radmayr, Christian ^a   Böck, Günther ^b   Herold, Manfred ^b   Klocker, Helmut ^a   Bartsch, Georg ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD83 ANTIGEN; CD86 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD86 PROTEIN, HUMAN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; CELL AGGREGATION; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; IMMUNOLOGY; METABOLISM; MYCOBACTERIUM BOVIS; PHENOTYPE; POLYMERASE CHAIN REACTION; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD86; CELL AGGREGATION; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; MYCOBACTERIUM BOVIS; PHENOTYPE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0030614674     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970106)70:1<128::AID-IJC19>3.0.CO;2-H     Document Type: Article

References (36)

1. AUSTYN, J.M., New insights into the mobilization and phagocytic activity of dendritic cells. J. exp. Med., 183, 1287-1292 (1996).
2. BOHLE, A., NOWC, C.H., ULMER, A.J., MUSEHOLD, J., GERDES, J., HOFSTETTER, A.G. and FLAD, H.D., Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guérin immunotherapy. J. Urol., 144, 59-63 (1990).
3. BRENNER, C.A., TAM, A.W., NELSON, P.A., ENGLEMAN, E.G., SUZUKI, N., FRY, K.E. and LARRICK, J.W., Message-amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Bio Techniques, 7, 1096-1103 (1989).
4. CAUX, C., VANBERVLIET, B., MASSACRIER, C., AZUMA, M., OKUMURA, M., LANIER, L.L. and BANCHEREAU, J., B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. exp. Med., 180, 1841-1847 (1994).
5. CELLUZZI, C., MAYORDOMO, J.I., STORKUS, W.J., LOTZE, M.T. and FALO, L.D., Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. exp. Med., 183, 283-287 (1996).
6. CHRISTMAS, T.J. and BOTTAZZO, G.F., Abnormal urothelial HLA-DR expression in interstitial cystitis. Clin. exp. Immunol., 87, 450-454 (1992).
7. DEKERNION, J.B. (ed.), Immunotherapy of urologic tumors, pp. 1-347, Churchill Livingstone, New York (1990).
8. DEVITA, V.T., JR., HELLMAN, S. and ROSENBERG, S.A. (eds.), Biological therapy of cancer, pp. 1-800, J.B. Lippincott, Philadelphia (1991).
9. FEARON, D.T. and LOCKSLEY, R.M., The instructive role of innate immunity in the acquired immune response. Science, 272, 50-54 (1996).
10. FLYNN, J.L., GOLDSTEIN, M.M., CHAN, J., TRIEBOLD, K.J., PFEFFER, K., LOWENSTEIN, C.J., SCHREIBER, R., MAK, T.W. and BLOOM, B.R., Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 2, 561-572 (1995).
11. HERR, H.W., SCHWALB, D.M., ZHANG, Z.-F, SOGANI, P.C., FAIR, W.R., WHITMORE, W.F. and OETTEGEN, H.F., Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow up of a prospective randomized trial. J. clin. Oncol., 13, 1404-1408 (1995).
12. HSU, F.J., BENIKE, C., FAGNONI, F., LILES, T.M., CZERWINSKI, D., TAIDI, B., ENGLEMAN, E.G. and LEVY, R., Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med., 2, 52-58 (1996).
13. INABA, K., INABA, M., DEGUCHI, M., HAGI, K., YASUMIZU, R., IKEHARA, S., MURAMATSU, S. and STEINMAN, R.M., Granulocytes, macrophages and dendritic cells arise from a common major-histocompatibility-complex-class-II-negative progenitor in mouse bone marrow. Proc. nat. Acad. Sci. (Wash.), 90, 3038-3042 (1993a).
14. INABA, K., INABA, M., NAITO, M. and STEINMAN, R.M., Dendritic-cell progenitors phagocytose particulates, including bacillus Calmette-Guérin organisms, and sensitize mice to mycobacterial antigens in vivo. J. exp. Med., 178, 479-488 (1993b).
15. KAUFMANN, S.H.E, and VAN EMBDEN, J.D.A., Tuberculosis, a neglected disease strikes back. Trends Microbiol., 1, 2-5 (1993).
16. KLOCKER, H., KASPAR, F., EBERLE, J., ÜBERREITER, S., RADMAYR, C. and BARTSCH, G., Point mutation in the DNA-binding domain of the androgen receptor in two families with Reifenstein syndrome. Amer. J. hum. Genet., 50, 1313-1327 (1992).
17. + T-cells. Cancer Res., 52, 4286-4290 (1992).
18. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, S.T., KAST, W.M., DELEO, A.B. and LOTZE, M.T., Bone-marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic anti-tumor immunity. Nature Med., 1, 1297-1302 (1995).
19. MCAVENY, K.M., GOMELLA, L.G. and LATTIME, E.C., Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy. Cancer Immunol. Immunother., 39, 401-406 (1994).
20. MORALES, A., EIDENGER, D. and BRUCE, A.W., Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J. Urol., 116, 180-183 (1976).
21. MORTON, D.L., Active immunotherapy against cancer: present status. Semin. Oncol., 13, 180-185 (1986).
22. PAGLIA, P., CHIODONI, C., RODOLFO, M. and COLOMBO, M.P., Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. exp. Med., 183, 317-322 (1996).
23. RADMAYR, C., BÖCK, G., HOBISCH, A., KLOCKER, H., BARTSCH, G. and THURNHER, M., Dendritic antigen-presenting cells from the peripheral blood of renal-cell-carcinoma patients. Int. J. Cancer, 63, 627-632 (1995).
24. ROAKE, J., RAO, A.S., MORRIS, P.J., LARSEN, C.P., HANKINS, D.F. and AUSTYN, J.M., Dendritic-cell loss from non-lymphoid tissue after systemic administration of lipopolysaccharide. tumor necrosis factor and interleukin-1. J. exp. Med., 181, 2237-2247 (1995).
25. ROMANI, N., GRUNER, S., BRANG, D., KÄMPGEN, E., LENZ, A., TROCKEN-BACHER, B., KONWALINKA, G., FRITSCH, P.O., STEINMAN, R.M. and SCHULER, G., Proliferating dendritic-cell progenitors in human blood. J. exp. Med., 180, 83-93 (1994).
26. SALLUSTO, F. and LANZAVECCHIA, A., Efficient presentation of soluble antigen by cultured human dendritic colony-stimulatingcells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α. J. exp. Med., 179, 1109-1118 (1994).
27. SALLUSTO, F., CELLA, M., DANIELI, C. and LANZAVECCHIA, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major-histocompability-complex-class-II compartment: down-regulation by cytokines and bacterial products. J. exp. Med., 182, 389-400 (1995).
28. SHIN, J.S., PARK, J.H., KIM, J.D., LEE, J.M. and KIM, S.J., Induction of tumor-necrosis-factor-α(TNF-α) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guérin. Clin. exp. Immunol., 100, 26-31 (1995).
29. STEINMAN, R.M., The dendritic-cell system and its role in immunogenicity. Ann. Rev. Immunol., 9, 271-297 (1991).
30. STEINMAN, R., HOFFMAN, L. and POPE, M., Maturation and migration of cutaneous dendritic cells. J. invest. Dermatol., 105, 2S-7S (1995).
31. + human blood dendritic cells for the active tumor immunotherapy. Exp. Hematol., (1996). (In press).
32. YOUNG, J.W. and INABA, K., Dendritic cells as adjuvants for class-I-major-histocompatibility-complex-restricted anti-tumor immunity. J. exp. Med., 183, 7-11 (1996).
33. ZHOU, L.-J. and TEDDER, T.F., Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol., 154, 3821-3835 (1995a).
34. + blood dendritic cells. Blood, 86, 3295-3301 (1995b).
35. + dendritic cells. Proc. nat. Acad. Sci. (Wash.), 93, 2588-2592 (1996).
36. ZITVOGEL, L., MAYORDOMO, J.I., TJANDRAWAN, T., DELEO, A.B., CLARKE, M.R., LOTZE, M.T. and STORKUS, W.J., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T-helper-cell-1-associated cytokines. J. exp. Med., 183, 87-97 (1996).